Kedudukan dalam Saham
#27026
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Perubahan (1 tahun)
-15.70%
Perdagangan Mabion S.A. (MAB)
Harga MAB dengan permodalan pasaran b
Modal pasaran bagi Mabion S.A.(MAB)
Modal Pasaran: $35.58M
Sehingga August 2026, Mabion S.A. mempunyai modal pasaran sebanyak $35.58M. Ini menjadikan Mabion S.A. syarikat ke-27026th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Mabion S.A. dari 2010 hingga 2026
MAB berbanding dengan 5 teratas yang paling popular stocks
| Harga MAB |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+14,896,838.91%
|
|
|
|
|
$4.634T
|
+13,022,380.47%
|
|
|
|
|
$4.143T
|
+11,642,848.27%
|
|
|
|
|
$3.589T
|
+10,087,053.06%
|
|
|
|
|
$2.857T
|
+8,028,734.03%
|
